KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $159.0 million.

  • Bristol Myers Squibb's Depreciation and Depletion fell 421.69% to $159.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $658.0 million, marking a year-over-year increase of 201.55%. This contributed to the annual value of $651.0 million for FY2024, which is 654.66% up from last year.
  • Bristol Myers Squibb's Depreciation and Depletion amounted to $159.0 million in Q3 2025, which was down 421.69% from $165.0 million recorded in Q2 2025.
  • Bristol Myers Squibb's 5-year Depreciation and Depletion high stood at $169.0 million for Q4 2024, and its period low was $135.0 million during Q1 2021.
  • Moreover, its 5-year median value for Depreciation and Depletion was $151.0 million (2023), whereas its average is $152.5 million.
  • Per our database at Business Quant, Bristol Myers Squibb's Depreciation and Depletion plummeted by 2058.82% in 2021 and then soared by 1167.88% in 2022.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Depreciation and Depletion stood at $137.0 million in 2021, then increased by 11.68% to $153.0 million in 2022, then grew by 6.54% to $163.0 million in 2023, then rose by 3.68% to $169.0 million in 2024, then fell by 5.92% to $159.0 million in 2025.
  • Its Depreciation and Depletion was $159.0 million in Q3 2025, compared to $165.0 million in Q2 2025 and $165.0 million in Q1 2025.